GlassScriptPhysician profile
Matthew Michael Callaghan
NPI 1619317492
$1,562.53
in general payments reported to CMS, 2019-2025
11 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $195 · 2021: $31.00 · 2023: $126 · 2024: $498 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.57 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $624.55 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Argon Medical Devices, INC. | $250.00 | 2024 | Clot Mgmt |
| Medtronic Vascular, INC. | $213.06 | 2019 | |
| Angiodynamics, INC. | $205.86 | 2024-2025 | Alphavac |
| Penumbra, INC. | $108.50 | 2023 | Penumbra System |
| Boston Scientific Corporation | $54.07 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered, Obsidio |
| Aidoc Medical LTD | $46.88 | 2025 | Briefcase |
| Bard Peripheral Vascular, INC. | $20.38 | 2024 | Venovo |
| W. L. Gore & Associates, INC. | $17.40 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Medtronic, INC. | $12.18 | 2021 | |
| Merit Medical Systems INC | $9.65 | 2024 | Corvocet Biopsy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Callaghan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.